https://investors.onkuretherapeutics.com/static-files/70aad19f-5b65-4706-ad20-6cc2bda2d892
https://investors.onkuretherapeutics.com/news-releases/news-release-details/onkure-announces-closing-merger-reneo-pharmaceuticals-and
https://investors.onkuretherapeutics.com/news-events/news-releases
Proprietary OKUR initiation reports from Oppenheimer and LifeSci
https://www.capricor.com/investors/news-events/press-releases/detail/293/capricor-therapeutics-announces-initiation-of-rolling
https://www.capricor.com/investors/news-events/press-releases/detail/294/capricor-therapeutics-announces-positive-long-term-data
https://www.capricor.com/our-science/publications
Oppenheimerâ€™s Proprietary Report on CAPR
https://ir.vikingtherapeutics.com/2024-10-09-Viking-Therapeutics-Announces-Results-from-Phase-1b-Clinical-Trial-of-VK0214-in-Patients-with-X-ALD
https://vandapharmaceuticalsinc.gcs-web.com/node/16161/pdf
https://ir.achievelifesciences.com/news-events/press-releases/detail/208/achieve-life-sciences-announces-completion-of-enrollment-in
https://gaintherapeutics.com/newsroom/press-releases/press-releases-2024/gain-therapeutics-to-present-at-michael-j-fox-foundations-16th-annual-parkinsons-disease-therapeutics-conference/
https://www.fiercepharma.com/pharma/win-compounders-fda-will-review-its-decision-put-eli-lillys-tirzepatide-its-shortage-list
https://www.reuters.com/legal/compounding-group-sues-fda-removing-lillys-weight-loss-drug-shortage-list-2024-10-07/
https://www.biospace.com/fda/lillys-tirzepatide-could-land-again-on-fda-drug-shortage-list-opens-door-for-compounders
https://www.baxter.com/baxter-newsroom/hurricane-helene-updates
https://www.fda.gov/drugs/updates-2024-hurricane-season/hurricane-helene-baxters-manufacturing-recovery-north-carolina
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-inavolisib-palbociclib-and-fulvestrant-endocrine-resistant-pik3ca-mutated-hr-positive
https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-hemophilia-or-b
